Karen Knudsen, Chief Executive Officer at Parker Institute for Cancer Immunotherapy, shared a post on LinkedIn:
“Loving the BioCentury Inc. ‘Grand Rounds‘ mtg in Seattle – geared toward connecting breakthroughs to investors like the Parker Institute.
In addition to the incredible science, I was thrilled to connect with the brilliant Jeffrey Bluestone, PICI board member and founding CEO.
I am grateful for you, Dr Bluestone!”
Other articles featuring Jeffrey Bluestone on OncoDaily.